BIOMAT Database Logo BIOMAT Database Logo

[Membrane microviscosity of myasthenic lymphocytes: a special reference on the temperature dependency (author's transl)]. 1978

S Arimori, and Y Shimizu, and K Sumitomo

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D001809 Blood Viscosity The internal resistance of the BLOOD to shear forces. The in vitro measure of whole blood viscosity is of limited clinical utility because it bears little relationship to the actual viscosity within the circulation, but an increase in the viscosity of circulating blood can contribute to morbidity in patients suffering from disorders such as SICKLE CELL ANEMIA and POLYCYTHEMIA. Blood Viscosities,Viscosities, Blood,Viscosity, Blood
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures

Related Publications

S Arimori, and Y Shimizu, and K Sumitomo
[Microviscosity of healthy T and B lymphocytes (author's transl)].
June 1978, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
S Arimori, and Y Shimizu, and K Sumitomo
[Studies on membrane microviscosity of human blood platelets (author's transl)].
June 1981, Rinsho byori. The Japanese journal of clinical pathology,
S Arimori, and Y Shimizu, and K Sumitomo
[Studies on lymphocytes subpopulations of the thymic lymphocytes obtained from myasthenic patients (author's transl)].
April 1974, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
S Arimori, and Y Shimizu, and K Sumitomo
Effect of specific antibodies on membrane microviscosity of human lymphocytes.
January 1979, Acta biochimica et biophysica; Academiae Scientiarum Hungaricae,
S Arimori, and Y Shimizu, and K Sumitomo
[Microviscosity and lipid composition of lymphocytes from myasthenia gravis and systemic lupus erythematosus (author's transl)].
August 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S Arimori, and Y Shimizu, and K Sumitomo
[Amyloidosis with special reference to kidneys (author's transl)].
January 1980, Przeglad lekarski,
S Arimori, and Y Shimizu, and K Sumitomo
[Studies on structure of glycoprotein, with special reference to takaamylase A (author's transl)].
January 1974, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
S Arimori, and Y Shimizu, and K Sumitomo
[ARDS - with special reference of septic lung (author's transl)].
October 1981, Nihon Kyobu Shikkan Gakkai zasshi,
S Arimori, and Y Shimizu, and K Sumitomo
[Immunological studies on whole saliva--with special reference to immunoglobulin A-- (author's transl)].
October 1977, Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases,
S Arimori, and Y Shimizu, and K Sumitomo
[Primary care--with special reference to neurosurgery (author's transl)].
May 1979, No shinkei geka. Neurological surgery,
Copied contents to your clipboard!